Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$95.5M
106M shares
52-week range
$0.85 – $2.22
3% from low
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NASDAQ
CS
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
www.hyperfine.ioNo one on the platform currently holds HYPR.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 730,233 | $788.7K |
| Execution date | Ratio |
|---|---|
| 2003-08-13 | 1-for-10reverse |
No one on the platform has traded HYPR yet.
$HYPR This will go down to 0.70 or a shade under before consolidation. Its going to need some real good news before year end or a cash crisis could T-Bone the stock.. i have owned it and not lost much on it but got out before earnings release. I just feel they are in a bind with limited scope atm and they will need cash .
View on StockTwits ↗$HYPR this would be a good place for insiders to make some buys, and show their confidence.
View on StockTwits ↗$BFLY Buckle up a voilent move is coming and it will leave many speechless and others in disbelief. BFLY has a huge pipeline despite the negative narrative from short sellers which are few and far between. If you follow smart money you will see only a handful of institutions are short. - Home healthcare commercial contract begins in Q4. - Pending FDA approval for 4th Gen chip - Apollo is in development and will likely be released to market in 2028 which is what MidJourney needs for their whole body scanners. - Workstations will be released in 2028 for hospitals seeking enterprise solutions - New partnerships for Butterfly Embedded, Butterfly Garden, Compass AI. - New revenue stream from entering the Brazil market - Software revenues will continue to grow. - BFLY transforming from a medical device to a semiconductor company. These are just a few in the pipeline. What’s coming will be epic in 2027! Few Understand 🦋 $ARKG $HYPR $AAPL $AAOI
View on StockTwits ↗$HYPR Always more of the same here. Mgmt CANNOT get sales traction, this name burns cash and now is fully using the ATM to dilute us longs!!!! Easier short ever if it gets back to $1.25.
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-8-6-hyperfine-inc-stock/ $HYPR Hyperfine Earnings Transcript
View on StockTwits ↗$HYPR such a small market cap…cmon HYPR! Light at end of tunnel to get movin!!
View on StockTwits ↗$HYPR 4th consecutive quarter with gross profit margin over 50%
View on StockTwits ↗$HYPR Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.09 up 25.00% YoY • Reported revenue of $3.9M up 44.81% YoY
View on StockTwits ↗$HYPR https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-inc-reports-second-quarter-2026-financial-results/
View on StockTwits ↗#DDAmanda Pick Alerts for July 30, 2026: $BIOT, $VERI, $HYPR, $MVST, $NAUT https://DDAmanda.com
View on StockTwits ↗$HYPR https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-announces-release-multiple-peer-reviewed-publications/
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $20M | +50.5% | $-0.35 | $-0.35–$-0.34 | — | 2 |
| 2027 | $26M | +30.4% | $-0.34 | $-0.34–$-0.33 | — | 1 |
| 2028 | $35M | +32.7% | $-0.31 | $-0.31–$-0.31 | — | 1 |
| 2029 | $29M | -15.7% | $-0.29 | $-0.29–$-0.29 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $-0.09 | $-0.09 | +0.0% |
| 2026-05-12 | $-0.09 | $-0.09 | +0.0% |
| 2026-03-18 | $-0.08 | $-0.08 | +0.0% |
| 2025-11-13 | $-0.10 | $-0.11 | -10.0% |
| 2025-08-13 | $-0.12 | $-0.12 | +0.0% |
| 2025-05-13 | $-0.12 | $-0.12 | +0.0% |
| 2025-03-17 | $-0.16 | $-0.14 | +12.5% |
| 2024-11-12 | $-0.14 |
| $-0.14 |
| +0.0% |
| $65M |
| — |
| LUNGPulmonx Corporation | $2.23 | +3.34% | $94M | — |
| NSPRInspireMD, Inc. | $0.86 | +2.95% | $41M | — |
Source: Financial Modeling Prep · peers by sector/industry